Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRDA | AZN | AMGN | GILD | BMY |
| Company | Entrada Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 11.37 | 182.63 | 346.56 | 136.80 | 56.80 |
| High | 11.72 | 186.22 | 352.58 | 138.37 | 57.69 |
| Low | 10.97 | 182.39 | 345.80 | 136.46 | 56.45 |
| Latest | 11.47 | 185.78 | 348.43 | 138.11 | 57.39 |
| Change | -0.02 | +1.71 | -1.34 | +0.77 | +0.39 |
| % Change | -0.17% | +0.93% | -0.38% | +0.56% | +0.68% |
| Volume | 174,543 | 1,574,495 | 2,276,236 | 6,525,747 | 11,950,150 |
| 20-Day Average Volume | 243,527 | 1,864,045 | 2,774,377 | 6,836,922 | 15,077,588 |
| Previous Close | 11.49 | 184.07 | 349.77 | 137.34 | 57.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.27 | 194.84 | 368.49 | 144.55 | 59.96 |
| 20-Day Raw Stochastic | 18.77% | 12.31% | 7.51% | 11.65% | 14.60% |
| 20-Day Relative Strength | 48.12 | 41.46 | 42.33 | 43.67 | 44.41 |
| Weighted Alpha | +33.95 | +26.23 | +16.86 | +26.14 | +5.74 |
| Today's Opinion | 64% Buy | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 64% Buy | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.90% since 03/17/26 | -2.88% since 03/17/26 | -3.52% since 03/17/26 | -4.36% since 03/17/26 | -3.89% since 03/17/26 |
| Low | 10.97 on 03/24/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 12.48 on 03/18/26 | 190.73 on 03/18/26 | 360.68 on 03/18/26 | 143.79 on 03/18/26 | 59.67 on 03/18/26 |
| 1-Month | |||||
| %Chg | -0.09% since 02/24/26 | -10.08% since 02/24/26 | -9.00% since 02/24/26 | -6.45% since 02/24/26 | -6.83% since 02/24/26 |
| Low | 10.97 on 03/24/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 13.65 on 03/11/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +8.41% since 12/24/25 | +0.48% since 12/24/25 | +4.33% since 12/24/25 | +9.90% since 12/24/25 | +4.90% since 12/24/25 |
| Low | 9.33 on 01/12/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 13.65 on 03/11/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +122.72% since 09/24/25 | +23.26% since 09/24/25 | +24.79% since 09/24/25 | +21.50% since 09/24/25 | +29.96% since 09/24/25 |
| Low | 5.18 on 09/25/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 13.65 on 03/11/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 439,883 | 285,475,648 | 188,549,792 | 170,496,768 | 116,079,024 |
| Shares Outstanding, K | 38,284 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 25,420,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -143,750,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,300,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -39,160,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -0.12 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 02/26/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.04 | 15.92 | 16.84 | 9.35 |